Trial Profile
Observation of using GLP-1 receptor agonist for wellness of brain activity in type 2 diabetes patients with mild cognitive impairment
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Jan 2018
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms OGAWA-MCI
- 19 Jan 2018 New trial record